Pfizer Eyes China Growth
Wall Street Journal
On Tuesday Pfizer announced that it would help Japan-based Takeda Pharmaceutical Co. market Actos, its leading drug for type 2 diabetes, in China. …
Pfizer expects 25% annual sales growth in ChinaChina Economic Review
Pfizer, Takeda to promote diabetes drug in ChinaReuters
Pfizer Gains Presence in Diabetes Market with Takeda DealSeeking Alpha (blog)
FiercePharma -Pharma Times -BusinessWeek
all 45 news articles »

Pfizer Eyes China Growth – Wall Street Journal

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks

Random Posts

Related posts:

  1. China Nuokang Bio-Pharmaceutical Files For IPO In US – Wall Street Journal
  2. Pfizer sees strong growth in China – Reuters
  3. Amylin, Takeda To Further Develop Obesity-Drug Combination – Wall Street Journal